Business Description
Vista Pharmaceuticals Ltd
ISIN : INE427C01021
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.2 | |||||
Debt-to-EBITDA | -2.54 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.58 | |||||
Beneish M-Score | -4.57 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 71.4 | |||||
3-Year EBITDA Growth Rate | -9 | |||||
3-Year EPS without NRI Growth Rate | -22.5 | |||||
3-Year FCF Growth Rate | 20.5 | |||||
3-Year Book Growth Rate | -1.1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.21 | |||||
9-Day RSI | 53.02 | |||||
14-Day RSI | 50.37 | |||||
6-1 Month Momentum % | 0.44 | |||||
12-1 Month Momentum % | -16.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.61 | |||||
Quick Ratio | 1.15 | |||||
Days Inventory | 313.73 | |||||
Days Sales Outstanding | 443.41 | |||||
Days Payable | 309.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.4 | |||||
Shareholder Yield % | 3.89 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 13.13 | |||||
Operating Margin % | -37.3 | |||||
Net Margin % | -43.7 | |||||
FCF Margin % | -56.46 | |||||
ROE % | -11.44 | |||||
ROA % | -7.78 | |||||
ROIC % | -6.73 | |||||
ROC (Joel Greenblatt) % | -11.36 | |||||
ROCE % | -9.05 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.2 | |||||
PB Ratio | 1.52 | |||||
Price-to-Tangible-Book | 1.99 | |||||
EV-to-EBIT | -22.9 | |||||
EV-to-EBITDA | -28.23 | |||||
EV-to-Revenue | 8.76 | |||||
EV-to-FCF | -15.2 | |||||
Price-to-Median-PS-Value | 1.74 | |||||
Price-to-Net-Current-Asset-Value | 10.48 | |||||
Earnings Yield (Greenblatt) % | -4.37 | |||||
FCF Yield % | -7.07 | |||||
Forward Rate of Return (Yacktman) % | 0.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vista Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 101.018 | ||
EPS (TTM) (₹) | -0.921 | ||
Beta | -0.37 | ||
Volatility % | 52.12 | ||
14-Day RSI | 50.37 | ||
14-Day ATR (₹) | 0.815849 | ||
20-Day SMA (₹) | 13.16 | ||
12-1 Month Momentum % | -16.04 | ||
52-Week Range (₹) | 10.43 - 19.32 | ||
Shares Outstanding (Mil) | 61.55 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vista Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vista Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Vista Pharmaceuticals Ltd Frequently Asked Questions
What is Vista Pharmaceuticals Ltd(BOM:524711)'s stock price today?
When is next earnings date of Vista Pharmaceuticals Ltd(BOM:524711)?
Does Vista Pharmaceuticals Ltd(BOM:524711) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |